Cas:136802-85-2 Bis(3,5-dimethyl-4-methoxyphenyl)chlorophosphine manufacturer & supplier

We serve Chemical Name:Bis(3,5-dimethyl-4-methoxyphenyl)chlorophosphine CAS:136802-85-2 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

Bis(3,5-dimethyl-4-methoxyphenyl)chlorophosphine

Chemical Name:Bis(3,5-dimethyl-4-methoxyphenyl)chlorophosphine
CAS.NO:136802-85-2
Synonyms:chloro-bis(4-methoxy-3,5-dimethylphenyl)phosphane;MFCD01630810;Chlorobis(3,5-dimethyl-4-methoxyphenyl)phosphine
Molecular Formula:C18H22ClO2P
Molecular Weight:336.79300
HS Code:

Physical and Chemical Properties:
Melting point:N/A
Boiling point:451.7ºC at 760 mmHg
Density:N/A
Index of Refraction:
PSA:32.05000
Exact Mass:336.10500
LogP:4.52390

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:UN3265
Packing Group:II


Contact us for information like chloro-bis(4-methoxy-3,5-dimethylphenyl)phosphane chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,Chlorobis(3,5-dimethyl-4-methoxyphenyl)phosphine physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,chloro-bis(4-methoxy-3,5-dimethylphenyl)phosphane Use and application,MFCD01630810 technical grade,usp/ep/jp grade.


Related News: CDMOs closely work with companies who want to pursue upcoming innovations in medicines, help cope with shortcomings of internal lab-to-manufacturing scale-up. kaempferol 7-O-β-D-glucopyranoside manufacturers Today’s announcement is strongly aligned to IDA Ireland’s Regional pillar and its continued commitment to winning jobs and investment in regional locations. I wish Charles River every success with this expansion.” Allyl 2-O-benzoyl-3-O-benzyl-a-L-rhamnopyranoside suppliers Only four out of the eight studies showed a reduction in ‘off’ time, and the effect did not increase with an increased dose of Nouryant.” sec-O-Glucosylhamaudol vendor & factory Elliott made its intention for a C-suite overhaul clear in an open letter early July. The activist investor called on GSK to appoint a new board directors with biopharma and consumer health expertise to select the leaders for the two companies. ,Today’s announcement is strongly aligned to IDA Ireland’s Regional pillar and its continued commitment to winning jobs and investment in regional locations. I wish Charles River every success with this expansion.”